Discovery of 3-(Indol-5-yl)-indazole Derivatives as Novel Myeloid Differentiation Protein 2/Toll-like Receptor 4 Antagonists for Treatment of Acute Lung Injury-Reference-Cited by-同舟云学术

Discovery of 3-(Indol-5-yl)-indazole Derivatives as Novel Myeloid Differentiation Protein 2/Toll-like Receptor 4 Antagonists for Treatment of Acute Lung Injury

Published:2019-04-18 Issue:11 Volume:62 Page:5453-5469
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Liu Zhiguo¹^ORCID,Chen Lingfeng²,Yu Pengtian¹³,Zhang Yali¹,Fang Bo¹,Wu Chao¹,Luo Wu¹,Chen Xianxin¹,Li Chenglong¹,Liang Guang¹²^ORCID

Affiliation:

1. Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China

2. School of Chemical Engineering, Nanjing University of Science and Technology, Nanjing, Jiangsu 210094, China

3. Department of Pharmacy, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310000, China

Funder

Ministry of Science and Technology of the People's Republic of China

National Natural Science Foundation of China

Natural Science Foundation of Zhejiang Province

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.9b00316

Reference54 articles.

1. Adult Respiratory Distress Syndrome: Risk with Common Predispositions

2. ACUTE RESPIRATORY DISTRESS IN ADULTS

3. Macrophage heterogeneity in tissues: phenotypic diversity and functions

4. The Acute Respiratory Distress Syndrome: Pathogenesis and Treatment

5. Role of TNFα in pulmonary pathophysiology

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of 3-bromoflavone derivative D5 as a novel TLR4-MD2 antagonist for treatment of acute lung injury and sepsis;Journal of Molecular Structure;2024-12

2. Ginsenoside Rh2 Alleviates LPS-Induced Inflammatory Responses by Binding to TLR4/MD-2 and Blocking TLR4 Dimerization;International Journal of Molecular Sciences;2024-09-02

3. Screening of Poria cocos polysaccharide with immunomodulatory activity and its activation effects on TLR4/MD2/NF-κB pathway;International Journal of Biological Macromolecules;2024-07

4. Fragment-Based Anti-inflammatory Agent Design and Target Identification: Discovery of AF-45 as an IRAK4 Inhibitor to Treat Ulcerative Colitis and Acute Lung Injury;Journal of Medicinal Chemistry;2024-06-24

5. The Role of Natural Products from Herbal Medicine in TLR4 Signaling for Colorectal Cancer Treatment;Molecules;2024-06-07